Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells

Oncology Reports

Volumn 33, Issue 3, 2015, Pages 1450-1458

  Wazir, Umar ^a,b   Sanders, Andrew J ^c   Wazir, Ali ^d   Baig, Ruqia Mehmood ^e   Jiang, Wen G ^c   Ster, Irina C ^b   Sharma, Anup K ^b   Mokbel, Kefah ^a,b,f  

^a Princess Grace Hospital   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^e PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

^f BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Adhesion; Apoptosis; Autophagy; Breast cancer; Cell cycle; DAP1; Death associated protein; ECIS; Growth assay; Invasion; QPCR

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CASPASE 8; CASPASE 9; CYCLIN D1; DEATH ASSOCIATED PROTEIN 1; DEATH LIGAND SIGNAL ENHANCER; INTERFERON BETA PROMOTER STIMULATOR 1; MESSENGER RNA; PHOSPHOPROTEIN; PROTEIN P21; UNCLASSIFIED DRUG; DAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; ELECTRIC CONDUCTIVITY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MCF 7 CELL LINE; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ELECTRIC CONDUCTIVITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; NEOPLASM INVASIVENESS;

EID: 84921635113     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3686     Document Type: Article

References (25)

1. Levy-Strumpf N and Kimchi A: Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 17:3331-3340, 1998.
2. Koren I, Reem E and Kimchi A: DAP1, a novel substrate of mTOR, negatively regulates autophagy. Curr Biol 20:1093-1098, 2010.
3. Gan B and Guan JL: FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal 20:787-794, 2008.
4. Wazir U, Jiang WG, Sharma AK and Mokbel K: The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters. Cancer Genomics Proteomics 9:199-201, 2012.
5. Tobin NP, Sims AH, Lundgren KL, Lehn S and Landberg G: Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer 11:417, 2011.
6. Liu Y, Encinas M, Comella JX, Aldea M and Gallego C: Basic helix-loop-helix proteins bind to TrkB and p21Cip1 promoters linking differentiation and cell cycle arrest in neuroblastoma cells. Mol Cell Biol 24:2662-2672, 2004.
7. Jiang WG, Grimshaw D, Lane J, Martin TA, Abounader R, Laterra J and Mansel RE: A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res 7:2555-2562, 2001.
8. Jia Y, Ye L, Ji K, et al: Death associated protein 1 is correlated with the clinical outcome of patients with colorectal cancer and has a role in the regulation of cell death. Oncol Rep 31:175-182, 2014.
9. Sanders AJ, Parr C, Mason MD and Jiang WG: Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro. Int J Mol Med 20:613-619, 2007.
10. Jiang WG, Redfern A, Bryce RP and Mansel RE: Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells. Prostaglandins Leukot Essent Fatty Acids 62:119-127, 2000.
11. Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 7:71, 2008.
12. Keese CR, Wegener J, Walker SR and Giaever I: Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 101:1554-1559, 2004.
13. Koren I, Reem E and Kimchi A: Autophagy gets a brake: DAP1, a novel mTOR substrate, is activated to suppress the autophagic process. Autophagy 6:1179-1180, 2010.
14. Degenhardt K, Mathew R, Beaudoin B, et al: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10:51-64, 2006.
15. Wazir U, Jiang W, Sharma A and Mokbel K: The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters. San Antonio Breast Cancer Symposium 2012, San Antonio, TX, USA. Cancer Res 72(24 Suppl):P1-04-07, 2012.
16. Gan B, Peng X, Nagy T, Alcaraz A, Gu H and Guan JL: Role of FIP200 in cardiac and liver development and its regulation of TNFα and TSC-mTOR signaling pathways. J Cell Biol 175:121-133, 2006.
17. Abbi S, Ueda H, Zheng C, et al: Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 13:3178-3191, 2002.
18. Melkoumian ZK, Peng X, Gan B, Wu X and Guan JL: Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 65:6676-6684, 2005.
19. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495-516, 2007.
20. Wazir U, Jiang WG, Sharma AK and Mokbel K: The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters. Anticancer Res 32:671-674, 2012.
21. Li HM, Fujikura D, Harada T, et al: IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation. Cell Death Differ 16:1615-1621, 2009.
22. O'Brien CA, Kreso A, Ryan P, et al: ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 21:777-792, 2012.
23. Wazir U, Kasem A, Sharma A, Jiang W and Mokbel K: mTORC1 and Rictor expression in human breast cancer: correlations with clinicopathological parameters and disease outcome. San Antonio Breast Cancer Symposium 2012, San Antonio, TX, USA. Cancer Res 72(24 Suppl):P1-04-09, 2012.
24. Gan B, Melkoumian ZK, Wu X, Guan KL and Guan JL: Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol 170:379-389, 2005.
25. De P, Miskimins K, Dey N and Leyland-Jones B: Promise of rapalogues versus mTOR kinase inhibitors in subset specific breast cancer: old targets new hope. Cancer Treat Rev 39:403-412, 2013.